1. Home
  2. CDT vs BBGI Comparison

CDT vs BBGI Comparison

Compare CDT & BBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • BBGI
  • Stock Information
  • Founded
  • CDT 2019
  • BBGI 1961
  • Country
  • CDT United States
  • BBGI United States
  • Employees
  • CDT N/A
  • BBGI N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • BBGI Broadcasting
  • Sector
  • CDT Health Care
  • BBGI Consumer Discretionary
  • Exchange
  • CDT Nasdaq
  • BBGI Nasdaq
  • Market Cap
  • CDT 11.1M
  • BBGI 13.2M
  • IPO Year
  • CDT N/A
  • BBGI 2000
  • Fundamental
  • Price
  • CDT $0.06
  • BBGI $8.40
  • Analyst Decision
  • CDT
  • BBGI
  • Analyst Count
  • CDT 0
  • BBGI 0
  • Target Price
  • CDT N/A
  • BBGI N/A
  • AVG Volume (30 Days)
  • CDT 104.2M
  • BBGI 8.1K
  • Earning Date
  • CDT 02-14-2025
  • BBGI 02-10-2025
  • Dividend Yield
  • CDT N/A
  • BBGI N/A
  • EPS Growth
  • CDT N/A
  • BBGI N/A
  • EPS
  • CDT N/A
  • BBGI 1.69
  • Revenue
  • CDT N/A
  • BBGI $238,754,777.00
  • Revenue This Year
  • CDT N/A
  • BBGI $2.55
  • Revenue Next Year
  • CDT N/A
  • BBGI N/A
  • P/E Ratio
  • CDT N/A
  • BBGI $5.07
  • Revenue Growth
  • CDT N/A
  • BBGI N/A
  • 52 Week Low
  • CDT $0.05
  • BBGI $7.60
  • 52 Week High
  • CDT $3.92
  • BBGI $18.80
  • Technical
  • Relative Strength Index (RSI)
  • CDT 42.52
  • BBGI 43.22
  • Support Level
  • CDT $0.08
  • BBGI $8.20
  • Resistance Level
  • CDT $0.18
  • BBGI $9.46
  • Average True Range (ATR)
  • CDT 0.02
  • BBGI 0.46
  • MACD
  • CDT -0.00
  • BBGI -0.07
  • Stochastic Oscillator
  • CDT 0.41
  • BBGI 13.16

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The Company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. The Company owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The Company currently operates three operating segments Audio, Digital and esports.

Share on Social Networks: